Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Felli

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancers|October 14, 2020
Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and DiagnosisMaria Beatrice Arasi, Francesca Pedini, Sonia Valentini, et al.
Blood|April 24, 2004
Potential role of APRIL as autocrine growth factor for megakaryocytopoiesisDésirée Bonci, Michael Hahne, Nadia Felli, et al.
Oncogene|April 13, 2004
Role of PLZF in melanoma progressionFederica Felicetti, Lisabianca Bottero, Nadia Felli, et al.
BMC Systems Biology|June 18, 2010
Hematopoietic differentiation: a coordinated dynamical process towards attractor stable statesNadia Felli, Luciano Cianetti, Elvira Pelosi, et al.
Haematologica|March 13, 2009
MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesisNadia Felli, Francesca Pedini, Paolo Romania, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesisNadia Felli, Francesca Pedini, Ann Zeuner, et al.
Frontiers in Oncology|July 11, 2022
MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAsGiorgia Castellani, Mariachiara Buccarelli, Valentina Lulli, et al.
Cancer Research|April 18, 2008
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanismsFederica Felicetti, M Cristina Errico, Lisabianca Bottero, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 23, 2019
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-ASimona Caporali, Adriana Amaro, Lauretta Levati, et al.
Molecular Oncology|May 23, 2019
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanomaFrancesca Pedini, Gabriele De Luca, Federica Felicetti, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancers|October 14, 2020
Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and DiagnosisMaria Beatrice Arasi, Francesca Pedini, Sonia Valentini, et al.
Blood|April 24, 2004
Potential role of APRIL as autocrine growth factor for megakaryocytopoiesisDésirée Bonci, Michael Hahne, Nadia Felli, et al.
Oncogene|April 13, 2004
Role of PLZF in melanoma progressionFederica Felicetti, Lisabianca Bottero, Nadia Felli, et al.
BMC Systems Biology|June 18, 2010
Hematopoietic differentiation: a coordinated dynamical process towards attractor stable statesNadia Felli, Luciano Cianetti, Elvira Pelosi, et al.
Haematologica|March 13, 2009
MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesisNadia Felli, Francesca Pedini, Paolo Romania, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesisNadia Felli, Francesca Pedini, Ann Zeuner, et al.
Frontiers in Oncology|July 11, 2022
MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAsGiorgia Castellani, Mariachiara Buccarelli, Valentina Lulli, et al.
Cancer Research|April 18, 2008
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanismsFederica Felicetti, M Cristina Errico, Lisabianca Bottero, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 23, 2019
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-ASimona Caporali, Adriana Amaro, Lauretta Levati, et al.
Molecular Oncology|May 23, 2019
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanomaFrancesca Pedini, Gabriele De Luca, Federica Felicetti, et al.
Pageof 2